Borrelia burgdorferi The C6 peptide is a crucial component in the serological diagnosis of Lyme disease. This peptide, derived from the VlsE protein of *Borrelia burgdorferi*, serves as a target for antibodies produced by the human body in response to infectionSeroreactivity to the C6 Peptide in Borrelia miyamotoi .... The C6 peptide ELISA (Enzyme-Linked Immunosorbent Assay) is a widely recognized and utilized method in borrelia serology for detecting these antibodies, thereby aiding in the diagnosis of Lyme disease.ReaScan+ C6 LYME IgG Its effectiveness has led to its recommendation by regulatory bodies like the Food and Drug Administration, often exhibiting high sensitivity and specificity.
The C6 peptide represents a conserved or invariable region (IR6) of the VlsE protein, a variable surface antigen found on *Borrelia burgdorferi*. Because it is a conserved region, it is less likely to be affected by the antigenic variation that *Borrelia* species employ to evade the host immune systemTruth About Lyme Disease Diagnostic Update. This makes antibodies targeting the C6 peptide a reliable indicator of infection. The C6 peptide ELISA test detects both IgG and IgM antibodies against this specific peptide.
The C6 peptide ELISA has demonstrated significant diagnostic performance, often improving upon traditional two-tiered testing approaches. Studies have indicated that the C6 ELISA can achieve high sensitivity and specificity values, sometimes exceeding 95%, for the diagnosis of Lyme disease. This can lead to earlier and more accurate detection of the infection, which is critical for timely treatment. The C6 peptide test has also been explored as a potential single-tier diagnostic tool, simplifying the diagnostic process. Furthermore, research suggests that a positive C6 test correlates well with acute borreliosis, and it may exhibit lower cross-reactivity with sera positive for other conditions compared to some other tests.
While primarily used for diagnosing Lyme disease, the C6 peptide test has also shown promise in identifying other related infections. Some studies suggest that the C6 peptide test may be helpful in identifying *Borrelia miyamotoi* infection, a tick-borne illness that can present with similar symptoms to Lyme disease.
It is important to note that the C6 peptide test is specifically designed to detect antibodies against *Borrelia burgdorferi* sensu stricto and related species. While it is a powerful diagnostic tool, it is part of a broader diagnostic strategy. Some research has also investigated the use of C6 peptide-based multiplex assays for a more comprehensive analysis of antibody responses.
An interesting aspect of the C6 peptide test is its applicability in individuals who have received the OspA vaccine for Lyme disease. In such cases, the C6 peptide ELISA can still be used to diagnose Lyme disease, as the antibodies detected are specific to the C6 peptide and not necessarily to the vaccine components.
Ongoing research continues to explore the full potential of the C6 peptide in diagnostics.作者：PJ Molloy·2018·被引用次数：50—The C6 peptide enzyme-linked immunosorbent assayis only used to diagnose Lyme disease. However, an evaluation of 24 patients from the northeastern United. This includes evaluating its performance in different clinical scenarios, such as neuroborreliosis, and its utility in conjunction with other diagnostic markers. The development of rapid tests, like the ReaScan+ C6 LYME IgG test, further enhances the accessibility and speed of Lyme disease diagnosis. Additionally, the synthesis of C6 peptides for research purposes, such as creating blocking peptides that bind to target antibodies and inhibit their activity, is also an area of interest.
In conclusion, the C6 peptide plays a vital role in the modern serological diagnosis of Lyme disease. Its ability to target conserved regions of the VlsE protein allows for sensitive and specific detection of antibodies, contributing to earlier diagnosis and more effective management of this tick-borne illness.
Join the newsletter to receive news, updates, new products and freebies in your inbox.